Vanda Pharmaceuticals
VNDA
#7496
Rank
ยฃ0.31 B
Marketcap
ยฃ5.36
Share price
1.75%
Change (1 day)
62.06%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ29.94 Million a decrease over its 2023 earnings that were of -ยฃ10.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million204.85%
2024 -ยฃ29.94 Million191.43%
2023 -ยฃ10.28 Million-320.45%
2022 ยฃ4.65 M-84.99%
2021 ยฃ31.04 M54.8%
2020 ยฃ20.05 M19.42%
2019 ยฃ16.79 M4.93%
2018 ยฃ16 M-228.6%
2017 -ยฃ12.45 Million-8.98%
2016 -ยฃ13.68 Million-53.79%
2015 -ยฃ29.59 Million-30.18%
2014 -ยฃ42.38 Million173.08%
2013 -ยฃ15.52 Million-25.33%
2012 -ยฃ20.78 Million163.61%
2011 -ยฃ7.89 Million-221.15%
2010 ยฃ6.5 M-124.53%
2009 -ยฃ26.53 Million-29.44%
2008 -ยฃ37.6 Million-36.2%
2007 -ยฃ58.93 Million21.81%
2006 -ยฃ48.38 Million170.55%
2005 -ยฃ17.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.70 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.03 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.50 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ18.94 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.50 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.86 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.07 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA